MétaCan
Menu
Back to cohort
Record W4312087161 · doi:10.1002/alz.067924

TRIAD multi‐dimensional biobank for biomarker discovery

2022· article· en· W4312087161 on OpenAlexaff
Jenna Stevenson, Nesrine Rahmouni, Mira Chamoun, Andréa Lessa Benedet, Alyssa Stevenson, Vanessa Pallen, Joseph Therriault, Firoza Z Lussier, Cécile Tissot, Gleb Bezgin, Tharick A. Pascoal, Paolo Vitali, Serge Gauthier, Pedro Rosa‐Neto

Bibliographic record

VenueAlzheimer s & Dementia · 2022
Typearticle
Languageen
FieldMedicine
TopicRadiomics and Machine Learning in Medical Imaging
Canadian institutionsDouglas Mental Health University InstituteMcGill UniversityMcGill University Health Centre
Fundersnot available
KeywordsBiobankBiomarkerCohortDementiaMedicineCohort studyBiomarker discoveryOncologyUrineInternal medicineDiseaseBioinformaticsBiology

Abstract

fetched live from OpenAlex

Abstract Background The Translational Biomarkers in Aging and Dementia (TRIAD) is a longitudinal, biomarker‐based cohort designed to study interactions between the pathophysiological processes driving to dementia. Currently, 50 million people worldwide have dementia [1]. PET and MRI imaging have been widely used to assess disease stage, though expensive and not readily accessible [2]. More recently though, breakthroughs in blood‐based biomarkers have proven a useful, available, and more cost‐effective way of evaluating amyloid and tau positivity. The TRIAD Biobank provides a unique framework to study disease stage using blood‐based biomarkers in conjunction with PET and CSF studies. Our cohort allows for validation of novel biomarkers as we simultaneously acquire gold standard second generation imaging acquisitions with full spectrum fluid biomarkers (CSF, saliva, plasma, urine). Importantly, the data acquired is integrated in a database compliant to multi‐dimensional biomarker analysis. Method Figure 1 depicts the cohort's banked fluids by diagnostic group. Figure 2 depicts the cohort's banked fluids by sex grouping. Result The TRIAD Biobank stores 1,034 blood samples from 655 participants, 658 of these being follow‐up collections. Additionally, cerebrospinal fluid has been collected from 381 individuals accounting for 520 collections in the bank, 812 urine collections from 662 individuals and 591 saliva samples from 432 individuals. Additionally, the cohort has collected 761 tau PET scans using [ 18 F]MK6240, 644 amyloid PET scans using [ 18 F]AZD4694 and 804 MRI using 3 Tesla. Conclusion With dementia being one of the leading, most costly causes of death, the need for early detection, more affordable, less invasive, and more readily available ways to determine disease stage is apparent [2]. The TRIAD multi‐dimensional biobank provides a wealth of resources to discover affordable biomarkers needed for early diagnosis and Alzheimer’s disease prevention. [1] Patterson, C. 2018. World Alzheimer Report 2018: The state of the art of dementia research, new frontiers . London, England: Alzheimer's Disease International [2] Gauthier S, Rosa‐Neto P, Morais JA, & Webster C. 2021. World Alzheimer Report 2021: Journey through the diagnosis of dementia . London, England: Alzheimer’s Disease International.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.011
metaresearch head score (Gemma)0.024
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.020
Threshold uncertainty score0.067

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0110.024
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0070.008
Science and technology studies0.0010.001
Scholarly communication0.0040.003
Open science0.0030.005
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0200.016

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.038
GPT teacher head0.323
Teacher spread0.285 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicRadiomics and Machine Learning in Medical ImagingFrench-language works237,207